Longitudinal Oral Microbiome Sampling for BE
Columbia University · with University of Michigan, National Cancer Institute (NCI) · NCT05133102
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 275
- US sites recruiting
- 2
- Study start
- March 19, 2021
- Record last updated
- May 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a longitudinal cohort study to assess the impact of repeated sampling of an oral microbiome signature for Barrett's esophagus (BE). Potential participants will be identified through chart review of patients who have had an endoscopy in the past three years.
Being studied: Sample collection
Conditions: Barrett Esophagus
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Scheduled for an upper endoscopy or had upper endoscopy within past three years
- Eighteen years of age or older
- Capable of producing a saliva sample
- Able to give informed consent
- For BE patients only: Endoscopic evidence of Barrett's esophagus (at least 1 cm maximal BE length; i.e. Prague classification: any C, M≥1), and intestinal metaplasia present on esophageal biopsies
Exclusion Criteria
- History of head and neck cancer or esophageal squamous cell or gastric cancer
- History of esophageal or gastric surgery
- Scheduled to undergo colonoscopy on the day of initial saliva collection
- Scheduled only for Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopy ultrasound (EUS) without accompanying standard upper endoscopy on the day of initial saliva collection
- For BE patients only: History of prior endoscopic therapy for BE except a history of prior Endoscopic mucosal resection (EMR) of focal lesions without subsequent ablative therapy is permitted
Recruiting US locations
University of Michigan
Ann Arbor, MI 48109
Site contact: Joel H. Rubenstein, MD · jhr@med.umich.edu
Columbia University Irving Medical Center
New York, NY 10032
Site contact: Julian Abrams, MD · 212-305-1909 · ja660@cumc.columbia.edu
Study contacts (from the official record)
- Julian Abrams, MD · 212-305-1909 · ja660@cumc.columbia.edu
- Katharine Boyce, RN · kb3217@cumc.columbia.edu
Similar studies in Michigan
All healthy volunteers studies in Michigan →- RecruitingHealthy volunteers
Tailoring a Home Supervision Intervention for Latinx Caregivers
Western Michigan University
- Location
- Kalamazoo, MI
- Eligibility basics
- Ages 18–99
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Allen Park, MI + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Prevail Therapeutics
- Location
- Farmington Hills, MI + 1 other US site
- Eligibility basics
- Ages 30–80